Prosecution Insights
Last updated: October 04, 2026
Application No. 18/947,087

COUPLEABLE WOUND CLOSURE MECHANISM AND METHODS OF MANUFACTURING AND USING SAME

Non-Final OA §102
Filed
Nov 14, 2024
Priority
May 14, 2022 — provisional 63/342,068 +2 more
Examiner
DANG, ANH TIEU
Art Unit
Tech Center
Assignee
Suturegard Medical Inc.
OA Round
1 (Non-Final)
66%
Grant Probability
Favorable
1-2
OA Rounds
1y 5m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
432 granted / 660 resolved
+5.5% vs TC avg
Strong +36% interview lift
Without
With
+35.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
40 currently pending
Career history
689
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
44.6%
+4.6% vs TC avg
§102
24.6%
-15.4% vs TC avg
§112
21.9%
-18.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 660 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicants’ election without traverse of Group I, Species G, Figures 17-19, claims 1-18 in the reply filed on September 8, 2026, is acknowledged. Claims 19-20 withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to a nonelected invention, there being no allowable generic or linking claim. Applicant timely traversed the restriction (election) requirement in the reply filed on September 8, 2026. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-18 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Lett et al (US 20210228415). Regarding claim 1, Lett et al (hereafter Lett) discloses a wound closure device comprising: a first portion (first bandage 14) including: a first elongated support layer (32); a first non-woven layer (24) coupled to the first elongated support layer; and a first fastening member (28 or 34) coupled to the first elongated support layer and disposed adjacent the first non-woven layer. Regarding claim 2, Lett discloses all of the limitations set forth in claim 1, further comprising: a second portion (second bandage 16) including: a second elongated support layer (32) having a first side and a second side; a second non-woven layer (24) coupled to the second elongated support layer on the first side; and a second fastening member (34 or28) coupled to the second elongated support layer on the second side. Regarding claim 3, Lett discloses all of the limitations set forth in claim 2, wherein the second fastening member of the second portion is configured and arranged to couple to the first fastening member of the first portion (figure 5B). Regarding claim 4, Lett discloses all of the limitations set forth in claim 3, wherein the first fastening member comprises hooks, and the second fastening member comprises loops, the hooks being releasably coupleable to the loops (paragraph 0040). Regarding claim 5, Lett discloses all of the limitations set forth in claim 3, wherein the second fastening member comprises hooks, and the first fastening member comprises loops, the hooks being releasably coupleable to the loops (paragraph 0040). Regarding claim 6, Lett discloses all of the limitations set forth in claim 2, wherein the first and second elongated support layers comprise a thermoplastic material (paragraph 0036). Regarding claim 7, Lett discloses all of the limitations set forth in claim 2, wherein the first and second elongated support layers comprise a rigid material (figure 5b, has sufficient rigidity to maintain shape). Regarding claim 8, Lett discloses all of the limitations set forth in claim 1, further comprising an adhesive layer (28) disposed on the first non-woven layer. Regarding claim 9, Lett discloses all of the limitations set forth in claim 8, further comprising a first removeable liner (30) at least partially covering the first non-woven layer. Regarding claim 10, Lett discloses a wound closure device comprising: a first portion (14) including: a first elongated support layer; a first non-woven layer (32) coupled to the first elongated support layer; at least one first fastening member (34) coupled to the first elongated support layer; and at least one first weakened region (36) disposed along an axis of the first portion so that the first portion may be divided into at least two segments. Regarding claim 11, Lett discloses all of the limitations set forth in claim 8 10, further comprising: a second portion (16) including: a second elongated support layer (24) having a first side and a second side; a second non-woven layer (28) coupled to the second elongated support layer on the first side; at least one second fastening member (34) coupled to the second elongated support layer on the second side; and at least one second weakened region (36) disposed along an axis of the second portion so that the second portion may be divided into at least two segments. Regarding claim 12, Lett discloses all of the limitations set forth in claim 11, wherein the second fastening member is configured and arranged to couple to the first fastening member of the first portion (figure 5B). Regarding claim 13, Lett discloses all of the limitations set forth in claim 11, wherein the at least one first fastening member comprises hooks, and the at least one second fastening member comprises loops, the hooks being releasably coupleable to the loops (paragraph 0040). Regarding claim 14, Lett discloses all of the limitations set forth in claim 11, wherein the at least one second fastening member comprises hooks, and the at least one first fastening member comprises loops, the hooks being releasably coupleable to the loops (paragraph 0040). Regarding claim 15, Lett discloses all of the limitations set forth in claim 11, wherein the first and second elongated support layers comprise a thermoplastic material (paragraph 0036). Regarding claim 16, Lett discloses all of the limitations set forth in claim 11, wherein the first weakened region (36) includes a first scored line extending across the first elongated support layer, the first non-woven layer and the at least one first fastening member, and wherein the second weakened region includes a second scored line extending across the second elongated support layer, the second non-woven layer and the at least one second fastening member (paragraph 0041). Regarding claim 17. Lett discloses all of the limitations set forth in claim 10, wherein the at least one first fastening member includes a plurality of fastening members spaced from one another (figure 5b, paragraph 0040). Regarding claim 18 Lett discloses all of the limitations set forth in claim 11, wherein the at least one second fastening member includes a plurality of fastening members spaced from one another (figure 5b, paragraph 0040). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANH TIEU DANG whose telephone number is (571)270-3221. The examiner can normally be reached Monday-Thursday (9am-4pm EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at (571) 272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANH T DANG/ Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Nov 14, 2024
Application Filed
Sep 23, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12741125
Devices and Methods for Insertion and/or Pressurization of a Balloon Catheter for Balloon Dilation of the Eustachian Tube and Other Anatomical Passageways Accessible Through the Nostril of a Human
1y 9m to grant Granted Sep 22, 2026
Patent 12734034
PERCUTANEOUS HEART VALVE DELIVERY SYSTEMS
4y 3m to grant Granted Sep 15, 2026
Patent 12734375
SHIELDING FEATURES FOR ULTRASONIC BLADE OF A SURGICAL INSTRUMENT
2y 12m to grant Granted Sep 15, 2026
Patent 12721790
DEVICES AND METHODS FOR A HYPER REALISTIC BREAST SHAPED SOOTHER
3y 4m to grant Granted Sep 01, 2026
Patent 12721643
SNARE DEVICE
2y 2m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
66%
Grant Probability
99%
With Interview (+35.5%)
3y 4m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 660 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month